Linked Life Data

18254158

Source:http://linkedlifedata.com/resource/pubmed/id/18254158

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
2008-2-12
pubmed:abstractText
Maternal serum levels of asymmetric dimethyl-arginine (ADMA), an endogenous inhibitor of endothelial nitric oxide synthase, are known to be increased in pregnant women with high-resistance placental circulation in the second trimester. The aim of the present study was to investigate the relationship between uterine artery resistance and maternal serum ADMA concentrations in the first trimester.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Feb
pubmed:issn
0960-7692
pubmed:author
pubmed:copyrightInfo
Copyright (c) 2008 ISUOG. Published by John Wiley & Sons, Ltd.
pubmed:issnType
Print
pubmed:volume
31
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
153-7
pubmed:meshHeading
pubmed:year
2008
pubmed:articleTitle
First-trimester uterine artery resistance and maternal serum concentration of asymmetric dimethylarginine.
pubmed:affiliation
Fetal Medicine Unit, Division of Obstetrics and Gynaecology, Division of Basic Medical Sciences, St George's, University of London, Cranmer Terrace, London, UK. federico.prefumo@libero.it
pubmed:publicationType
Journal Article